CMS releases draft guidance on the third round of medical insurance drug price negotiation plan

On May 13th, the Centers for Medicare and Medicaid Services (CMS) released draft guidance on the third round of Medicare drug price negotiations, which includes policies to improve negotiation transparency, prioritize the inclusion of high cost prescription drugs in Medicare, and policies to minimize the negative impact of negotiated fair maximum prices on drug innovation in the United States.